Browsing by Author Crombie, C.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2006Outpatient fractionated ifosfamide, carboplatin and etoposide as salvage therapy in relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma.Bradstock, Kenneth; Gottlieb, David; Hertzberg, Mark; Benson, W.; Crombie, C.; Taper, J.; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)Outpatient fractionated ifosfamide, carboplatin and etoposide as salvage therapy in relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma., Annals of Oncology 2005, vol.17 Suppl 4,(N/A),2006,pp iv25-iv30
2003Outpatient-based ifosfamede, carboplatin and etoposide (ICE) chemotherapy in transplant-eligible patients with non-Hodgkin's lymphoma and Hodgkin's diseaseBradstock, Kenneth; Gottlieb, David; Hertzberg, Mark; Benson, W.; Crombie, C.; Taper, J.; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)Outpatient-based ifosfamede, carboplatin and etoposide (ICE) chemotherapy in transplant-eligible patients with non-Hodgkin's lymphoma and Hodgkin's disease, Annals of Oncology, vol.14,(Supplement 1),2003,pp i11-i16
2015Patients' and doctors' preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: What makes it worthwhile?Hudson, Malcolm; Muljadi, Nick; Stockler, Martin; Veillard, Anne-Sophie; Blinman, Prunella L; Christmas, Tim; Crombie, C.; Flynn, Peter; Hughes, Brett; McLachlan, Sue-Anne; Millward, Michael; Windsor, Morgan; Wright, Gavin; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentrePatients' and doctors' preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: What makes it worthwhile?, European Journal of Cancer, vol.51, 12, 2015,pp 1529-1537
2005Phase II study of docetaxel and celecoxib as first or second line therapy in patients with advanced NSCLCBoyer, Michael; Hui, Rina; Yip, Desmond; Blackwell, T.; Chern, B.; Crombie, C.; Hawson, G.; Links, Matthew; Underhill, Craig; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); MedicinePhase II study of docetaxel and celecoxib as first or second line therapy in patients with advanced NSCLC, Lung cancer, vol.49,(Sup.2),2005,pp S272-S273
2015A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trialBoyer, Michael; Chan, Matthew; Chinchen, Sarah; Coskinas, Xanthi; Espinoza, David; Pavlakis, Nick; Stockler, Martin; Tognela, Annette; Veillard, Anne-Sophie; Abdi, E; Begbie, S; Boyce, Adam; Briscoe, Karen; Crombie, C.; Davidson, A; et al, Various; Huighes, B G M; Lewis, C R; Long, J; Varma, S; Central Clinical School: Medicine; Northern Clinical School: Melanoma Institute of Australia; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreA phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial, Annals of Oncology, vol.26, 11, 2015,pp 2280-2286